openPR Logo
Press release

Albumin Market Estimated to Exceed US$ 7.7 Billion Globally By 2027

07-21-2022 10:08 AM CET | Health & Medicine

Press release from: IMARC Group

Albumin Market

Albumin Market

According to IMARC Group latest report titled "Albumin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027", offers a comprehensive analysis of the industry, which comprises insights on albumin market. The report also includes competitor and regional analysis, and contemporary advancements in the global market. The global albumin market reached a value of US$ 5.4 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 7.7 Billion by 2027, exhibiting a CAGR of 6.15% during 2022-2027.

Albumin refers to the water-soluble globular protein present in blood plasma. It is synthesized in the liver and is essential for maintaining the blood volume and transportation of enzymes, bile salt molecules, hormones, etc. Albumin is widely available in human, bovine, and recombinant variants. It is vital for sustaining the intravascular colloid osmotic pressure (COP) and preventing leakage of fluids into the tissue. Albumin is utilized as a blood volumizer to treat rare diseases, burns, liver disorders, blood loss trauma, etc. As a result, it finds extensive applications in drug delivery systems, therapeutics, culture media, vaccines, etc.

Request to Get the Free Sample Report: https://www.imarcgroup.com/albumin-market/requestsample

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Market Trends:

The growing prevalence of chronic medical ailments across the globe is primarily driving the albumin market. In line with this, the expanding geriatric population, which is more susceptible to such conditions, is also propelling the market growth. Furthermore, the escalating utilization of albumin for the development of drugs and stable vaccine formulations is catalyzing the product demand. Besides this, the increasing adoption of human serum albumin (HSA) to replenish proteins in the human plasma and maintain plasma colloid oncotic pressure is acting as another growth-inducing factor. Additionally, the introduction of product-based nanoparticles and the rising number of R&D activities in the field of biotechnology are projected to bolster the albumin market in the coming years.

Explore Full Report with Table of Contents: https://www.imarcgroup.com/albumin-market

Competitive Landscape with Key players:

The report has also analysed the competitive landscape of the market with some of the key players being.
• Albumedix Ltd
• Biotest AG
• Celgene Corporation (Bristol-Myers Squibb Company)
• CSL Limited
• Grifols SA
• HiMedia Laboratories
• Medxbio Pte Ltd
• Merck KGaA
• Octapharma AG
• Takeda Pharmaceutical Company Limited
• Thermo Fisher Scientific Inc.
• Ventria Bioscience Inc

Albumin Market Segmentation:
Our report has categorized the market based on region, product, application and end use industry.

Breakup by Product:
• Human Serum Albumin
• Bovine Serum Albumin
• Recombinant Albumin

Breakup by Application:
• Therapeutics
• Drug Formulation and Vaccine
• Component of Media
• Others

Breakup by End User:
• Hospitals and Clinics
• Pharmaceutical and Biotechnology Companies
• Research Institutes

Breakup by Region:
• North America (United States, Canada)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key highlights of the report:
• Market Performance (2016-2021)
• Market Outlook (2022-2027)
• Porter's Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

We are updating our reports, If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Competitive landscape, etc. Click request free sample report, the report will be delivered to you in PDF format via email within 24 to 48 hours after the payment confirmation.

Contact US:
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Albumin Market Estimated to Exceed US$ 7.7 Billion Globally By 2027 here

News-ID: 2686538 • Views:

More Releases from IMARC Group

GCC Pet Food Market Size is Expected to Reach USD 422.9 Million By 2033 | CAGR: 5.3%
GCC Pet Food Market Size is Expected to Reach USD 422.9 Million By 2033 | CAGR: …
GCC Pet Food Market Overview Market Size in 2024: USD 266.2 Million Market Size in 2033: USD 422.9 Million Market Growth Rate 2025-2033: 5.3% According to IMARC Group's latest research publication, "GCC Pet Food Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", the GCC pet food market size was valued at USD 266.2 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 422.9 Million by 2033, exhibiting a
GCC Residential Real Estate Market Size to Worth USD 147.77 Billion by 2033 | With a 7.50% CAGR
GCC Residential Real Estate Market Size to Worth USD 147.77 Billion by 2033 | Wi …
GCC Residential Real Estate Market Overview Market Size in 2024: USD 73.31 Billion Market Size in 2033: USD 147.77 Billion Market Growth Rate 2025-2033: 7.50% According to IMARC Group's latest research publication, "GCC Residential Real Estate Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", the GCC residential real estate market size was valued at USD 73.31 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 147.77 Billion by
GCC Drones Market Size to Surpass USD 2,005.3 Million by 2033 | With a 13.3% CAGR
GCC Drones Market Size to Surpass USD 2,005.3 Million by 2033 | With a 13.3% CAG …
GCC Drones Market Overview Market Size in 2024: USD 588.2 Million Market Size in 2033: USD 2,005.3 Million Market Growth Rate 2025-2033: 13.3% According to IMARC Group's latest research publication, "GCC Drones Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", The GCC drones market size was valued at USD 588.2 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 2,005.3 Million by 2033, exhibiting a growth rate of
Medical Imaging Market to Surpass USD 70.8 Billion by 2033, at a CAGR of 5.03%
Medical Imaging Market to Surpass USD 70.8 Billion by 2033, at a CAGR of 5.03%
Market Overview: The medical imaging market is experiencing rapid growth, driven by Growing Burden of Chronic and Age-Related Diseases, Expansion of Government-Funded Health Infrastructure and Technological Advancements in Imaging Modalities. According to IMARC Group's latest research publication, "Medical Imaging Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", The global medical imaging market size reached USD 44.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach

All 5 Releases


More Releases for Albumin

rHu Albumin Market Key Players Analysis - Merck KGaA, HiMedia Laboratories Pvt. …
"rHu Albumin Market" in terms of revenue was estimated to be worth $94.88 million in 2023 and is poised to reach $218.56 million by 2031, growing at a CAGR of 11.16% from 2024 to 2031 according to a new report by Insight Ace Analytic. Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1482 Latest Drivers Restraint and Opportunities Market Snapshot: Key factors influencing the global rHu Albumins market are: • Increase in
Rhu Albumin Market Future Business Opportunities 2024-2031 | Albumin Bioscience, …
The Latest research report on the Rhu Albumin Market 2024 provides a comprehensive analysis of the current market landscape, with forecasts extending to 2031. This study combines qualitative and quantitative insights to highlight significant market developments, challenges, competitive dynamics, and potential opportunities and trends shaping the Rhu Albumin Market. The report covers market size, recent trends, growth projections, market share, and development status. Additionally, it examines government policies, market dynamics,
Rhu Albumin Market Growth in Future Scope 2024-2031 | HiMedia Laboratories Pvt. …
Rhu Albumin Market Trends Overview 2024-2031: A new Report by Coherent Market Insights, titled "Rhu Albumin Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031," offers a comprehensive analysis of the industry, which comprises insights on the Rhu Albumin market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market. This report has a complete table of contents, figures, tables, and charts, as well as insightful
rHu Albumin Market: A Catalyst for Innovation in Trauma Care, Albumin Replacemen …
"rHu Albumin Market" in terms of revenue was estimated to be worth $94.88 million in 2023 and is poised to reach $218.56 million by 2031, growing at a CAGR of 11.16% from 2024 to 2031 according to a new report by Insight Ace Analytic. Get Free Sample Report @ https://www.insightaceanalytic.com/request-sample/1482 Latest Drivers Restraint and Opportunities Market Snapshot: Key factors influencing the global rHu Albumins market are: • Increase in prevalence of rare diseases,
Exploring the Growing Demand for Albumin in the Global Albumin Market
Introduction: Albumin is a protein that is primarily produced by the liver and is found in human blood plasma. It plays a crucial role in maintaining the osmotic pressure of blood and transporting various substances such as hormones, fatty acids, and drugs. Albumin is widely used in various medical applications such as blood volume expansion, treatment of burns, liver diseases, and hypovolemic shock. With the growing prevalence of chronic diseases such
Albumin Market: Therapeutic Action of Albumin on Liver Function and Blood Circul …
The use of albumin to treat multiple types of deficiencies, including those related to blood volume, is giving an impetus to market growth. It is a high-utility, human-derived protein that has applications across a spectrum of medical operations. Conditions such as hypoalbuminemia, caused by severe injuries, and rapid protein loss due to third-degree burns can be effectively managed through intravenous administration of albumin. Furthermore, albumin administration is the last resort